Triple-S Management Corporation (GTS)
(Delayed Data from NYSE)
$24.15 USD
+1.09 (4.73%)
Updated May 3, 2019 04:02 PM ET
After-Market: $24.16 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$24.15 USD
+1.09 (4.73%)
Updated May 3, 2019 04:02 PM ET
After-Market: $24.16 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
7 Low Price-to-Sales Stocks With Favorable Growth Dynamics
by Zacks Equity Research
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by the company.
5 Solid Reasons to Invest in Anthem for Portfolio Boost
by Zacks Equity Research
Riding high on growing membership and a robust capital position, Anthem (ANTM) holds great prospects to reap profitable returns for investors.
Zacks.com featured highlights include: Big Lots, Hub, Domtar, Hitachi, Avnet, GMS and Triple-S
by Zacks Equity Research
Zacks.com featured highlights include: Big Lots, Hub, Domtar, Hitachi, Avnet, GMS and Triple-S
7 Low Price-to-Sales Stocks to Add Value to Your Portfolio
by Zacks Equity Research
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by the company.
Triple-S Management (GTS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Triple-S Management (GTS) delivered earnings and revenue surprises of 25.71% and 0.78%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Humana (HUM) Jointly Buys Curo, Boosts Medicare Business
by Zacks Equity Research
Humana (HUM) completes its joint acquisition of Curo with WCAS to expand its Medicare Advantage business.
Humana (HUM) Hits 52-Week High, Is Further Upside Left?
by Zacks Equity Research
Riding high on Kindred Healthcare acquisition and a recent rating affirmation, Humana's (HUM) shares reach a 52-week high on July 6.
Ensign Boosts Skilled Nursing Facility With McCall Buyout
by Zacks Equity Research
Ensign's (ENSG) acquisition of McCall reflects its strategy to expand in the growing skilled nursing market.
Humana Jointly Acquires Kindred, Expands Into Patient Care
by Zacks Equity Research
Humana (HUM) jointly acquires Kindred to expand its geographical presence.
4 Top Health Insurance Stocks of 1H With Room to Run in 2H
by Sapna Bagaria
Rise in membership, revenue diversification, healthy balance sheet and cost control are behind the strong performance in 1H.
Molina Healthcare to Sell MMS Unit for Business Streamlining
by Zacks Equity Research
Molina Healthcare's (MOH) impending sale of its unit is in line with its business restructuring initiatives.
4 Solid Reasons to Retain Anthem (ANTM) in Your Portfolio
by Zacks Equity Research
Riding high on four factors, Anthem (ANTM) holds great potential to generate high returns for investors.
Molina Healthcare Hits 52 Week High: Is Further Upside Left?
by Zacks Equity Research
Molina Healthcare's (MOH) receipt of Florida Medicaid contract and a clearer visibility on its turnaround initiatives appear to appreciate its stock price.
Triple-S Management (GTS) Soared to a 52-Week-High, Time to Cash Out?
by Zacks Equity Research
Triple-S Management Corporation is at a 52 week high, but can investors hope for more gains in the future? We take a look at the fundamentals for GTS for clues.
Humana or Anthem: Which is a Better Health Insurance Stock?
by Zacks Equity Research
Both Humana and Anthem stocks look attractive in a thriving health insurance industry.
Molina Healthcare Clinches Medicaid Contracts in Florida
by Zacks Equity Research
Molina Healthcare's (MOH) unit wins Medicaid Managed Care contracts from the Florida Agency.
Triple-S Management (GTS) Soars to a 52-Week High, Time to Cash Out?
by Zacks Equity Research
Triple-S Management Corporation is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for GTS for clues.
Zacks Industry Outlook Highlights: WellCare Health Plans, Anthem and Triple-S Management
by Zacks Equity Research
Zacks Industry Outlook Highlights: WellCare Health Plans, Anthem and Triple-S Management
5 Reasons Why You Must Add Humana (HUM) to Your Portfolio
by Zacks Equity Research
Humana (HUM) looks promising to garner better returns for investors owing to five factors.
Triple-S Management (GTS) Soars to a 52-Week High, Time to Cash Out?
by Zacks Equity Research
Triple-S Management Corporation is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for GTS for clues.
5 Reasons to Add WellCare Health Plans to Your Portfolio
by Zacks Equity Research
WellCare Health Plans (WCG) looks lucrative, promising better yield for investors on the back of five factors.
Centene Up More Than 80% This Year, Is Further Upside Left?
by Zacks Equity Research
Centene (CNC) stock's price movement reflects its strong operating performance and strategic inorganic growth measures.
Why Teladoc (TDOC) Is Up More Than 110% So Far This Year
by Zacks Equity Research
Teladoc (TDOC) stock seems to be favored by its rapidly growing revenue base and leadership position in underpenetrated telehealth services industry.
Tenet Plans to Sell Conifer & Reduce Costs, Issues '18 View
by Zacks Equity Research
Tenet Healthcare (THC) is following several initiatives in order to propel the overall growth of the company.
Centene (CNC) Reiterates '17 View & Issues '18 Guidance
by Zacks Equity Research
Centene (CNC) recently reaffirmed its 2017 guidance and issued strong outlook for 2018.